Trial results for a study investigating Powered Orthotic Exoskeleton Training in Stroke were posted on ClinicalTrials.gov on 2025-06-10. The study, which enrolled 22 participants, reported a statistically significant within-group improvement in the Five Times Sit to Stand Test for the exoskeleton training group (p=0.007).

Background

Stroke is a leading cause of long-term disability, frequently resulting in impaired walking ability, reduced independence, and a diminished quality of life. These gait disturbances, coupled with decreased physical activity, often lead to reduced muscle strength in the affected leg and cardiovascular deconditioning. Addressing mobility limitations is crucial for stroke survivors. The study explored the use of a novel battery-powered device, the Keeogo powered orthotic exoskeleton, which assists knee movement during walking, sitting, and standing by monitoring hip movement, aiming to improve functional mobility.

Trial design

This completed study, designated as Phase NA, enrolled 22 participants with Stroke. The trial investigated the effects of Powered Orthotic Exoskeleton Training. Participants were divided into a Powered Orthotic Exoskeleton Training Group and a Control Group. The study assessed various functional mobility outcomes, including the Five Times Sit to Stand Test (5xSTS), Six Minute Walk Test (6MWT), Ten Meter Walk Test (10MWT), and Timed Up and Go (TUG) Test.

Key results

Key measurements and analyses from the trial include:

What this means

The results indicate that powered orthotic exoskeleton training may offer significant benefits for stroke patients in improving sit-to-stand functional mobility. The statistically significant within-group improvements observed in the Five Times Sit to Stand Test (p=0.007 when not wearing the device, and p=0.04 when wearing it) suggest that this training can enhance a crucial aspect of daily living activities. While other mobility measures like the Six Minute Walk Test, Ten Meter Walk Test, and Timed Up and Go Test showed numerical changes, these did not reach statistical significance in the within-group analyses (p>0.05). These findings highlight the potential of exoskeleton-assisted therapy to improve specific functional tasks for stroke survivors, warranting further investigation in larger trials.

Source

The information regarding these trial results was obtained from ClinicalTrials.gov, a public database of clinical studies. The results for the study NCT04241848, titled "Powered Orthotic Exoskeleton Training in Stroke", were posted on 2025-06-10 on clinicaltrials.gov.